Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for AMRN

Stock Name	Amarin Corporation PLC
Ticker	AMRN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US0231112063
LEI	5493009JFIGUFEVPK217

Show aggregate AMRN holdings

News associated with AMRN

Amarin (NASDAQ:AMRN) Stock Price Crosses Above 200 Day Moving Average – Should You Sell?: Amarin Corporation PLC (NASDAQ:AMRN – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $12.50 and traded as high as $15.20. Amarin shares last traded at $14.97, with a volume of 38,257 shares trading hands. Analyst […] - 2025-09-12 04:44:46
Validea Kenneth Fisher Strategy Daily Upgrade Report - 9/4/2025: The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.AMARIN CORPORATION P - 2025-09-04 06:34:37
Amarin (NASDAQ:AMRN) Stock Passes Above 200-Day Moving Average – Should You Sell?: Amarin Corporation PLC (NASDAQ:AMRN – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $12.37 and traded as high as $15.48. Amarin shares last traded at $15.04, with a volume of 46,346 shares changing hands. Wall […] - 2025-09-04 04:20:53
Amarin (NASDAQ:AMRN) Lowered to “Hold” Rating by Zacks Research: Zacks Research cut shares of Amarin (NASDAQ:AMRN – Free Report) from a strong-buy rating to a hold rating in a research note released on Monday morning,Zacks.com reports. A number of other brokerages also recently issued reports on AMRN. Wall Street Zen raised Amarin from a “hold” rating to a “buy” rating in a research report […] - 2025-08-28 02:52:45
Validea Kenneth Fisher Strategy Daily Upgrade Report - 7/29/2025: The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.AMARIN CORPORATION P - 2025-07-29 06:42:35
Take the Zacks Approach to Beat the Markets: Amarin, Mogo, 3M in Focus: Zacks' model upgrades drove major gains for Amarin, Mogo and 3M, even as broader markets wobbled on tariff fears. - 2025-07-14 10:06:00
Amarin (NASDAQ:AMRN) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says: Amarin (NASDAQ:AMRN – Get Free Report) had its price objective upped by investment analysts at The Goldman Sachs Group from $7.00 to $12.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “sell” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s price target would suggest […] - 2025-06-27 02:28:43
Amarin (NASDAQ:AMRN) Shares Cross Above Two Hundred Day Moving Average – Should You Sell?: Amarin Corporation PLC (NASDAQ:AMRN – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $10.52 and traded as high as $12.74. Amarin shares last traded at $12.60, with a volume of 62,500 shares changing hands. Wall Street Analyst Weigh In […] - 2025-06-24 05:14:54
Amarin (NASDAQ:AMRN) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?: Amarin Co. plc (NASDAQ:AMRN – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $10.28 and traded as high as $10.57. Amarin shares last traded at $10.52, with a volume of 65,233 shares trading hands. Analysts Set New Price Targets AMRN has […] - 2025-05-16 04:55:04
Head-To-Head Analysis: Amarin (NASDAQ:AMRN) and Blueprint Medicines (NASDAQ:BPMC): Blueprint Medicines (NASDAQ:BPMC – Get Free Report) and Amarin (NASDAQ:AMRN – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, earnings, analyst recommendations and dividends. Analyst Recommendations This is a summary of recent ratings […] - 2025-05-09 02:53:16
Amarin (NASDAQ:AMRN) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell?: Shares of Amarin Co. plc (NASDAQ:AMRN – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $10.40 and traded as high as $11.20. Amarin shares last traded at $11.18, with a volume of 77,915 shares trading hands. Analyst Upgrades and Downgrades A […] - 2025-04-25 04:23:05
Amarin (NASDAQ:AMRN) Now Covered by Analysts at StockNews.com: Equities researchers at StockNews.com assumed coverage on shares of Amarin (NASDAQ:AMRN – Get Free Report) in a research note issued on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Amarin Price Performance NASDAQ:AMRN opened at $9.81 on Wednesday. The company’s 50-day simple moving average is $9.86 and its 200 day simple […] - 2025-04-16 03:11:03
Amarin (NASDAQ:AMRN) Earns Sell Rating from Analysts at StockNews.com: StockNews.com initiated coverage on shares of Amarin (NASDAQ:AMRN – Free Report) in a research note published on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Amarin Stock Up 1.8 % Amarin stock opened at $0.45 on Monday. The company has a market capitalization of $184.02 million, a PE ratio of […] - 2025-04-01 02:36:45
Amarin (NASDAQ:AMRN) Upgraded at StockNews.com: StockNews.com upgraded shares of Amarin (NASDAQ:AMRN – Free Report) from a sell rating to a hold rating in a research note released on Friday. Amarin Trading Down 0.8 % Shares of Amarin stock opened at $0.53 on Friday. Amarin has a 12-month low of $0.43 and a 12-month high of $1.11. The stock has a […] - 2025-03-10 04:05:06
Amarin (NASDAQ:AMRN) Cut to Sell at StockNews.com: StockNews.com downgraded shares of Amarin (NASDAQ:AMRN – Free Report) from a hold rating to a sell rating in a research report released on Tuesday morning. Amarin Trading Up 0.6 % Shares of Amarin stock opened at $0.58 on Tuesday. The company’s 50-day moving average price is $0.54 and its two-hundred day moving average price is […] - 2025-02-26 06:28:57

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) AMRN holdings

Date	Number of AMRN Shares Held	Base Market Value of AMRN Shares	Local Market Value of AMRN Shares	Change in AMRN Shares Held	Change in AMRN Base Value	Current Price per AMRN Share Held	Previous Price per AMRN Share Held

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AMRN by Blackrock for IE00BYXG2H39

Show aggregate share trades of AMRN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-07-16 BUY 1,721 15.850 16.070 16.048 USD 27,619 5.25
2025-04-17 BUY 1 9.110 9.340 9.317 USD 9 0.87
2025-04-11 SELL -194,032 9.300 10.100 10.020 USD -1,944,201 0.53 Loss of -1,841,837 on sale
2025-04-10 SELL -6,000 9.000 9.400 9.360 USD -56,160 0.53 Loss of -52,990 on sale
2025-04-08 SELL -751 8.600 9.200 9.140 USD -6,864 0.53 Loss of -6,466 on sale
2025-04-07 SELL -751 8.200 8.800 8.740 USD -6,564 0.53 Loss of -6,165 on sale
2025-04-04 SELL -3,755 8.000 8.400 8.360 USD -31,392 0.53 Loss of -29,392 on sale
2025-04-01 BUY 3,004 8.800 9.200 9.160 USD 27,517 0.53
2025-03-31 SELL -2,253 9.000 9.000 9.000 USD -20,277 0.54 Loss of -19,070 on sale
2025-03-14 SELL -12,048 8.200 8.600 8.560 USD -103,131 0.55 Loss of -96,533 on sale
2025-03-07 SELL -1,506 10.600 11.000 10.960 USD -16,506 0.55 Loss of -15,672 on sale
2025-03-04 SELL -753 10.200 10.800 10.740 USD -8,087 0.55 Loss of -7,669 on sale
2025-02-25 BUY 1,506 11.600 11.800 11.780 USD 17,741 0.56
2025-02-19 SELL -753 11.800 12.200 12.160 USD -9,156 0.55 Loss of -8,740 on sale
2025-02-13 BUY 2,259 12.200 12.400 12.380 USD 27,966 0.55
2025-02-12 BUY 753 11.200 11.800 11.740 USD 8,840 0.55
2025-02-11 BUY 3,008 10.400 10.600 10.580 USD 31,825 0.55
2025-01-17 BUY 3,008 11.200 11.200 11.200 USD 33,690 0.54
2025-01-16 BUY 3,004 11.000 11.200 11.180 USD 33,585 0.54
2025-01-10 SELL -1,504 11.000 11.400 11.360 USD -17,085 0.54 Loss of -16,272 on sale
2025-01-08 SELL -3,008 11.000 11.400 11.360 USD -34,171 0.54 Loss of -32,546 on sale
2024-12-30 SELL -3,765 8.800 9.000 8.980 USD -33,810 0.54 Loss of -31,762 on sale
2024-11-18 SELL -11,307 9.400 10.000 9.940 USD -112,392 0.59 Loss of -105,731 on sale
2024-11-08 SELL -754 11.400 11.600 11.580 USD -8,731 0.59 Loss of -8,284 on sale
2024-10-21 SELL -754 11.400 11.800 11.760 USD -8,867 0.00 Loss of -8,867 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-07-16	BUY	1,721	15.850	16.070	16.048	USD 27,619	5.25
2025-04-17	BUY	1	9.110	9.340	9.317	USD 9	0.87
2025-04-11	SELL	-194,032	9.300	10.100	10.020	USD -1,944,201	0.53 Loss of -1,841,837 on sale
2025-04-10	SELL	-6,000	9.000	9.400	9.360	USD -56,160	0.53 Loss of -52,990 on sale
2025-04-08	SELL	-751	8.600	9.200	9.140	USD -6,864	0.53 Loss of -6,466 on sale
2025-04-07	SELL	-751	8.200	8.800	8.740	USD -6,564	0.53 Loss of -6,165 on sale
2025-04-04	SELL	-3,755	8.000	8.400	8.360	USD -31,392	0.53 Loss of -29,392 on sale
2025-04-01	BUY	3,004	8.800	9.200	9.160	USD 27,517	0.53
2025-03-31	SELL	-2,253	9.000	9.000	9.000	USD -20,277	0.54 Loss of -19,070 on sale
2025-03-14	SELL	-12,048	8.200	8.600	8.560	USD -103,131	0.55 Loss of -96,533 on sale
2025-03-07	SELL	-1,506	10.600	11.000	10.960	USD -16,506	0.55 Loss of -15,672 on sale
2025-03-04	SELL	-753	10.200	10.800	10.740	USD -8,087	0.55 Loss of -7,669 on sale
2025-02-25	BUY	1,506	11.600	11.800	11.780	USD 17,741	0.56
2025-02-19	SELL	-753	11.800	12.200	12.160	USD -9,156	0.55 Loss of -8,740 on sale
2025-02-13	BUY	2,259	12.200	12.400	12.380	USD 27,966	0.55
2025-02-12	BUY	753	11.200	11.800	11.740	USD 8,840	0.55
2025-02-11	BUY	3,008	10.400	10.600	10.580	USD 31,825	0.55
2025-01-17	BUY	3,008	11.200	11.200	11.200	USD 33,690	0.54
2025-01-16	BUY	3,004	11.000	11.200	11.180	USD 33,585	0.54
2025-01-10	SELL	-1,504	11.000	11.400	11.360	USD -17,085	0.54 Loss of -16,272 on sale
2025-01-08	SELL	-3,008	11.000	11.400	11.360	USD -34,171	0.54 Loss of -32,546 on sale
2024-12-30	SELL	-3,765	8.800	9.000	8.980	USD -33,810	0.54 Loss of -31,762 on sale
2024-11-18	SELL	-11,307	9.400	10.000	9.940	USD -112,392	0.59 Loss of -105,731 on sale
2024-11-08	SELL	-754	11.400	11.600	11.580	USD -8,731	0.59 Loss of -8,284 on sale
2024-10-21	SELL	-754	11.400	11.800	11.760	USD -8,867	0.00 Loss of -8,867 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AMRN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	11,390	1,526	39,530	28.8%
2025-09-18	6,860	0	23,050	29.8%
2025-09-17	21,179	0	49,740	42.6%
2025-09-16	7,732	0	19,308	40.0%
2025-09-15	19,238	0	41,361	46.5%
2025-09-12	10,282	3,083	28,287	36.3%
2025-09-11	5,851	0	19,808	29.5%
2025-09-10	9,923	0	25,329	39.2%
2025-09-09	10,515	0	41,554	25.3%
2025-09-08	6,763	0	20,563	32.9%
2025-09-05	8,484	0	20,586	41.2%
2025-09-04	7,528	0	28,907	26.0%
2025-09-03	5,884	125	21,930	26.8%
2025-09-02	5,428	0	16,188	33.5%
2025-08-29	10,626	700	29,699	35.8%
2025-08-28	11,913	0	24,789	48.1%
2025-08-27	5,923	350	24,580	24.1%
2025-08-26	9,942	0	25,459	39.1%
2025-08-25	15,425	0	47,140	32.7%
2025-08-22	6,866	0	18,007	38.1%
2025-08-21	7,588	0	20,347	37.3%
2025-08-20	13,627	125	31,957	42.6%
2025-08-19	7,750	45	29,276	26.5%
2025-08-18	19,416	0	60,037	32.3%
2025-08-15	8,884	19	39,340	22.6%
2025-08-14	20,977	0	52,777	39.7%
2025-08-13	7,759	0	31,066	25.0%
2025-08-12	22,687	0	39,983	56.7%
2025-08-11	13,267	64	26,313	50.4%
2025-08-08	24,405	0	47,736	51.1%
2025-08-07	5,075	20	20,952	24.2%
2025-08-06	8,115	0	21,848	37.1%
2025-08-05	7,186	39	19,699	36.5%
2025-08-04	8,787	0	32,774	26.8%
2025-08-01	12,805	0	42,355	30.2%
2025-07-31	7,355	0	24,046	30.6%
2025-07-30	9,786	0	41,384	23.6%
2025-07-29	13,724	549	49,058	28.0%
2025-07-28	15,244	0	37,752	40.4%
2025-07-25	11,108	0	31,469	35.3%
2025-07-24	7,548	0	18,765	40.2%
2025-07-23	7,558	0	22,347	33.8%
2025-07-22	11,477	759	29,334	39.1%
2025-07-21	7,736	0	32,346	23.9%
2025-07-18	6,961	0	21,019	33.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE